October 2026
ACI Group secures UK and Ireland distribution partnership for clinically backed Bimuno® GOS
Ingredient distributor and supply chain expert ACI Group has expanded its health and nutrition portfolio with the addition of Bimuno® GOS, a prebiotic ingredient that stands out as one of the most extensively studied prebiotic ingredients available today. Now available to ACI Group’s customers across the UK and Ireland, the multi-award-winning Bimuno GOS is backed by more than 135 scientific publications exploring its role in supporting areas such as gut, immune and cognitive health, including over 25 clinical trials
:quality(80))
The appointment as UK and Ireland distribution partner for prebiotic specialist Clasado Biosciences strengthens ACI Group’s premium nutraceutical range and reinforces its strategy of partnering with scientifically credible manufacturers to help customers develop differentiated, evidence-based products. The partnership also gives UK and Irish manufacturers reliable access to a clinically researched ingredient, supported by local technical and commercial expertise.
The addition comes as demand for clinically substantiated gut health solutions climbs. Future Market Insights forecasts the UK prebiotic fibre market to grow at a CAGR of 5.8% between 2025 and 2035, yet most UK adults still consume around 18g of fibre a day against a recommended 30g. That persistent fibre gap represents a clear commercial opportunity for formulators.
Gareth Clark, Sales Director at ACI Group, explained: "What attracted us to Bimuno GOS is that it is a genuinely differentiated ingredient, combining an extensive body of clinical research with a low effective dose. That gives formulators real flexibility while meeting growing consumer demand for evidence-backed solutions in different applications such as capsules, tablets, powder supplements, stick packs and gummies. We take a strategic approach with our customers, helping them develop premium, science-led products that solve genuine formulation challenges rather than simply competing on price. Bimuno GOS aligns perfectly with our philosophy, and we see significant and exciting opportunities across gut health, active nutrition, women's health and healthy ageing."
Through the partnership, ACI will support brand owners and contract manufacturers from concept through to commercial launch, combining technical guidance, formulation expertise, strategic account development and marketing support to accelerate new product innovation.
Marcelo Durante, VP of Sales & Marketing at Clasado, added: "ACI Group is one of the most knowledgeable partners in the UK and Ireland health and nutrition market, and it's an ideal home for Bimuno GOS. This partnership brings together our world-leading microbiome science with ACI's commercial and technical expertise. This combination will help formulators create genuinely differentiated products."
Manufacturers interested in incorporating Bimuno GOS into new or existing formulations can contact ACI Group for technical guidance, application support and samples. Please visit https://acigroup.biz/ for more information.